An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people MR Nelson, D Wegmann, MG Ehm, D Kessner, P St. Jean, C Verzilli, ... Science 337 (6090), 100-104, 2012 | 799 | 2012 |
Broadening the horizon–level 2.5 of the HUPO-PSI format for molecular interactions S Kerrien, S Orchard, L Montecchi-Palazzi, B Aranda, AF Quinn, N Vinod, ... BMC biology 5, 1-11, 2007 | 308 | 2007 |
The minimum information required for reporting a molecular interaction experiment (MIMIx) S Orchard, L Salwinski, S Kerrien, L Montecchi-Palazzi, M Oesterheld, ... Nature biotechnology 25 (8), 894-898, 2007 | 288 | 2007 |
Characterization of a Mycobacterium tuberculosis H37Rv transposon library reveals insertions in 351 ORFs and mutants with altered virulence RA McAdam, S Quan, DA Smith, S Bardarov, JC Betts, FC Cook, ... Microbiology 148 (10), 2975-2986, 2002 | 149 | 2002 |
The application of next-generation sequencing technologies to drug discovery and development PM Woollard, NAL Mehta, JJ Vamathevan, S Van Horn, BK Bonde, ... Drug discovery today 16 (11-12), 512-519, 2011 | 76 | 2011 |
Minipig and beagle animal model genomes aid species selection in pharmaceutical discovery and development JJ Vamathevan, MD Hall, S Hasan, PM Woollard, M Xu, Y Yang, X Li, ... Toxicology and applied pharmacology 270 (2), 149-157, 2013 | 68 | 2013 |
Matching disease and phenotype ontologies in the ontology alignment evaluation initiative I Harrow, E Jiménez-Ruiz, A Splendiani, M Romacker, P Woollard, ... Journal of biomedical semantics 8, 1-13, 2017 | 65 | 2017 |
Ontology mapping for semantically enabled applications I Harrow, R Balakrishnan, E Jimenez-Ruiz, S Jupp, J Lomax, J Reed, ... Drug discovery today 24 (10), 2068-2075, 2019 | 60 | 2019 |
The European nucleotide archive in 2022 J Burgin, A Ahamed, C Cummins, R Devraj, K Gueye, D Gupta, V Gupta, ... Nucleic Acids Research 51 (D1), D121-D125, 2023 | 51 | 2023 |
Deep resequencing unveils genetic architecture of ADIPOQ and identifies a novel low-frequency variant strongly associated with adiponectin variation LL Warren, L Li, MR Nelson, MG Ehm, J Shen, DJ Fraser, JL Aponte, ... Diabetes 61 (5), 1297-1301, 2012 | 49 | 2012 |
An integrated data driven approach to drug repositioning using gene-disease associations J Mullen, SJ Cockell, P Woollard, A Wipat PloS one 11 (5), e0155811, 2016 | 47 | 2016 |
A community standard format for the representation of protein affinity reagents DE Gloriam, S Orchard, D Bertinetti, E Björling, E Bongcam-Rudloff, ... Molecular & Cellular Proteomics 9 (1), 1-10, 2010 | 39 | 2010 |
Linkage analysis of 7 polymorphic markers at chromosome 11p11. 2‐11q13 in 27 multiple endocrine neoplasia type 1 families RV Thakker, C Wooding, JT Pang, B Farren, B Harding, DC Anderson, ... Annals of human genetics 57 (1), 17-25, 1993 | 38 | 1993 |
NIX: a nucleotide identification system at the HGMP-RC GW Williams, PM Woollard, P Hingamp URL: http://www. hgmp. mrc. ac. uk/NIX, 1998 | 32 | 1998 |
Mining integrated semantic networks for drug repositioning opportunities J Mullen, SJ Cockell, H Tipney, PM Woollard, A Wipat PeerJ 4, e1558, 2016 | 24 | 2016 |
A case study: semantic integration of gene–disease associations for type 2 diabetes mellitus from literature and biomedical data resources D Rebholz-Schuhmann, C Grabmüller, S Kavaliauskas, S Croset, ... Drug discovery today 19 (7), 882-889, 2014 | 23 | 2014 |
Towards virtual knowledge broker services for semantic integration of life science literature and data sources I Harrow, W Filsell, P Woollard, I Dix, M Braxenthaler, R Gedye, D Hoole, ... Drug discovery today 18 (9-10), 428-434, 2013 | 16 | 2013 |
Safety and efficacy of iron oxide black, red and yellow for all animal species G Aquilina, G Azimonti, V Bampidis, M de Lourdes Bastos, G Bories, ... Efsa Journal 14 (6), 1-16, 2016 | 13 | 2016 |
Genetic variation MR Barnes, G Breen Humana, 2009 | 12 | 2009 |
Asking complex questions of the genome without programming PM Woollard Genetic Variation: Methods and Protocols, 39-52, 2010 | 10 | 2010 |